20 May 2025
Research out this week finds that a combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukaemia (B-ALL), the most common cancer in childhood and one that can be particularly difficult to treat in older patients. In recent years, new treatments have...
SCI-TIF community gathers for 3rd Annual Networking Dinner
29 April 2025
Last week, the Cambridge Stem Cell Institute Technology & Innovation Forum (SCI-TIF) celebrated its 3rd Annual Networking Dinner at Homerton College, Cambridge. This event brought together leading scientists from academia and industry, reinforcing SCI-TIF’s mission to unite the Cambridge stem cell community and foster...
Professor Sarah Teichmann announced as new member of the American Academy of Arts & Sciences
24 April 2025
Professor Sarah Teichmann FMedSci FRS, Chair in Stem Cell Medicine at the University of Cambridge (Cambridge Stem Cell Institute & Dept Medicine), and Group Leader at CSCI, has been announced this week as one of the newest members of the prestigious American Academy of Arts & Sciences . Sarah says, “ It is a...
Groundbreaking discovery from Tzelepis Lab could revolutionise treatment for deadly blood cancers
23 April 2025
A new study from Dr Konstantinos Tzelepis at the Cambridge Stem Cell Institute has discovered a new way to detect and target Acute Myeloid Leukaemia (AML), a fast growing, aggressive, blood cancer that requires urgent treatment. The research was published today (23 April) in Nature Biotechnology. AML is the second most...
If you'd like to make a donation to the the Cambridge Stem Cell Institute, please email comms@stemcells.cam.ac.uk or donate using the button below.
Sign up to our newsletter to stay up to date with news and events from the Cambridge stem cell community.
You can also find us on
© 2025 University of Cambridge
